Technology
Health
Pharmaceutical

Aratana Therapeutics

$3.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-4.18%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PETX and other stocks, options, ETFs, and crypto commission-free!

About

Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. Read More NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.

Employees
83
Headquarters
Leawood, Kansas
Founded
2010
Market Cap
175.99M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
419.25K
High Today
$3.89
Low Today
$3.66
Open Price
$3.83
Volume
142.68K
52 Week High
$7.16
52 Week Low
$3.30

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Biopharmaceutical
Pets
Cats

Earnings

-$0.26
-$0.08
$0.09
$0.27
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.14 per share
Actual
-$0.18 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.